Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus. | N Engl J Med | 2022 | 35294813 | PubTator, text mining | PubMed |
| Cereblon, a novel target in heart failure: but is calcium really everything? | Eur Heart J | 2022 | 35292822 | PubTator, text mining | PubMed |
| Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches. | Front Immunol | 2022 | 35273598 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress. | Cells | 2022 | 35269473 | PubTator, text mining | PubMed |
| Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas. | Cancers (Basel) | 2022 | 35267584 | PubTator, text mining | PubMed |
| Strategies to Reduce the On-Target Platelet Toxicity of Bcl-xL Inhibitors: PROTACs, SNIPERs and Prodrug-Based Approaches. | Chembiochem | 2022 | 35263486 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Clinical considerations for the design of PROTACs in cancer. | Mol Cancer | 2022 | 35249548 | PubTator, text mining | PubMed |
| Characterization of a rare mosaic unbalanced translocation of t(3;12) in a patient with neurodevelopmental disorders. | Mol Cytogenet | 2022 | 35248119 | PubTator, text mining | PubMed |
| MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape. | Mol Cell | 2022 | 35245435 | PubTator, text mining | PubMed |
| Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors? | Front Cell Dev Biol | 2022 | 35242765 | PubTator, text mining | PubMed |
| PROTACs technology for treatment of Alzheimer's disease: Advances and perspectives. | Acta Mater Med | 2022 | 35237768 | PubTator, text mining | PubMed |
| Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis. | Alzheimers Dement | 2022 | 35234334 | PubTator, text mining | PubMed |
| High-resolution structures of the bound effectors avadomide (CC-122) and iberdomide (CC-220) highlight advantages and limitations of the MsCI4 soaking system. | Acta Crystallogr D Struct Biol | 2022 | 35234143 | PubTator, text mining | PubMed |
| Selective Wee1 degradation by PROTAC degraders recruiting VHL and CRBN E3 ubiquitin ligases. | Bioorg Med Chem Lett | 2022 | 35231578 | PubTator, text mining | PubMed |
| Multiple Myeloma Patient Tumors With High Levels of Cereblon Exon-10 Deletion Splice Variant Upregulate Clinically Targetable Pro-Inflammatory Cytokine Pathways. | Front Genet | 2022 | 35222546 | PubTator, text mining | PubMed |
| Replacing the phthalimide core in thalidomide with benzotriazole. | J Enzyme Inhib Med Chem | 2022 | 35220840 | PubTator, text mining | PubMed |
| New Insights on the Nuclear Functions and Targeting of FAK in Cancer. | Int J Mol Sci | 2022 | 35216114 | PubTator, text mining | PubMed |
| EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis. | Nat Cell Biol | 2022 | 35210568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=64